Cell labeling for 19F MRI: New and improved approach to perfluorocarbon nanoemulsion design

Biosensors

Volumn 3, Issue 3, 2013, Pages 341-359

  Patel, Sravan K ^a   Williams, Jonathan ^a   Janjic, Jelena M ^a  

^a DUQUESNE UNIVERSITY   (United States)

Author keywords

Cell labeling; Imaging; stability; Nanoemulsion; Perfluorocarbon

Indexed keywords

CELL CULTURE; CELLS; DROPS; POLYDISPERSITY;

CELL LABELLING; DROPLET POLYDISPERSITIES; DROPLETS SIZES; EX-VIVO; IMAGING;; IN-VIVO; NANOEMULSION; NONINVASIVE TECHNIQUE; PERFLUOROCARBON NANOEMULSION; PERFLUOROCARBONS;

MAGNETIC RESONANCE IMAGING;

FLUOROCARBON;

ARTICLE; CELL CULTURE; CELL LABELING; CENTRIFUGATION; DISPERSION; EX VIVO STUDY; FLUORINE NUCLEAR MAGNETIC RESONANCE; IMMUNE SYSTEM; METHODOLOGY; NANOEMULSION; NUCLEAR MAGNETIC RESONANCE IMAGING; PARTICLE SIZE; QUALITY CONTROL; RELIABILITY; SEDIMENTATION; TEMPERATURE;

EID: 84888780650     PISSN: None     EISSN: 20796374     Source Type: Journal    
DOI: 10.3390/bios3030341     Document Type: Article

References (35)

1. Riess, J.G.; Krafft, M.P. Fluorinated materials for in vivo oxygen transport (blood substitutes), diagnosis and drug delivery. Biomaterials 1998, 19, 1529-1539.
2. Ahrens, E.T.; Zhong, J. In vivo MRI cell tracking using perfluorocarbon probes and fluorine-19 detection. NMR Biomed. 2013, 26, 860-871.
3. Janjic, J.M.; Ahrens, E.T. Fluorine-containing nanoemulsions for MRI cell tracking. Rev. Nanomed. Nanobiotechnol. 2009, 1, 492-501.
4. Winter, P.M.; Neubauer, A.M.; Caruthers, S.D.; Harris, T.D.; Robertson, J.D.; Williams, T.A.; Schmieder, A.H.; Hu, G.; Allen, J.S.; Lacy, E.K.; et al. Endothelial α(v)β3 integrin-targeted fumagillin nanoparticles inhibit angiogenesis in atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 2006, 26, 2103-2109.
5. 19F MR/optical imaging nanoprobes for the labeling of phagocytic and nonphagocytic immune cells. Biomaterials 2010, 31, 4964-4971.
6. O'Hanlon, C.E.; Amede, K.G.; O'Hear, M.R.; Janjic, J.M. NIR-labeled perfluoropolyether nanoemulsions for drug delivery and imaging. J. Fluor. Chem. 2012, 137, 27-33.
7. Patel, S.K.; Patrick, M.J.; Pollock, J.A.; Janjic, J.M. Two-color fluorescent (NIR and visible) triphasic perfluorocarbon nanoemuslions. J. Biomed. Opt. 2013, 18, 101312, doi:10.1117/ 1.JBO.18.10.101312.
8. Patel, S.K.; Zhang, Y.; Pollock, J.A.; Janjic, J.M. Cyclooxgenase-2 inhibiting perfluoropoly (ethylene glycol) ether theranostic nanoemulsions-In vitro study. PLoS One 2013, 8, e55802, doi:10.1371/journal.pone.0055802.
9. Janjic, J.M.; Srinivas, M.; Kadayakkara, D.K.; Ahrens, E.T. Self-delivering nanoemulsions for dual fluorine-19 MRI and fluorescence detection. J. Am. Chem. Soc. 2008, 130, 2832-2841.
10. 19F MRI detection of acute allograft rejection with in vivo perfluorocarbon labeling of immune cells. Magn. Reson. Med. 2011, 65, 1144-1153.
11. Van Heeswijk, R.B.; de Blois, J.; Kania, G.; Gonzales, C.; Blyszczuk, P.; Stuber, M.; Eriksson, U.; Schwitter, J. Selective in vivo visualization of immune-cell infiltration in a mouse model of autoimmune myocarditis by fluorine-19 cardiac magnetic resonance. Circ. Cardiovasc. Imaging 2013, 6, 277-284.
12. Balducci, A.; Wen, Y.; Zhang, Y.; Helfer, B.M.; Hitchens, T.K.; Meng, W.S.; Wesa, A.K.; Janjic, J.M. A novel probe for the non-invasive detection of tumor-associated inflammation. Oncoimmunology 2013, 2, e23034, doi:10.4161/onci.23034.
13. Ahrens, E.T.; Flores, R.; Xu, H.; Morel, P.A. In vivo imaging platform for tracking immunotherapeutic cells. Nat. Biotechnol. 2005, 23, 983-987.
14. 19F MRI. Magn. Reson. Med. 2009, 62, 747-753.
15. Pittsburgh, C.I. Celsense, Pitt Trial to "See" Cells Fight Cancer. Available online: http://www.post-gazette.com/stories/business/news/celsense-pitt-trial-to-see-cells-fight-cancer-305182/ (accessed on 10 September 2013).
16. Helfer, B.M.; Balducci, A.; Nelson, A.D.; Janjic, J.M.; Gil, R.R.; Kalinski, P.; de Vries, I.J.; Ahrens, E.T.; Mailliard, R.B. Functional assessment of human dendritic cells labeled for in vivo (19)F magnetic resonance imaging cell tracking. Cytotherapy 2010, 12, 238-250.
17. McClements, D.J. Nanoemulsions versus microemulsions: Terminology, differences, and similarities. Soft Matter. 2012, 8, 1719-1729.
18. Wooster, T.J.; Golding, M.; Sanguansri, P. Impact of oil type on nanoemulsion formation and Ostwald ripening stability. Langmuir 2008, 24, 12758-12765.
19. Klein, D.H.; Burtner, D.B.; Trevino, L.A.; Arlauskas, R.A. Particle size distribution of concentrated perfluorocarbon emulsions by sedimentation field flow fractionation. Biomater. Artif. Cells Immobil. Biotechnol. 1992, 20, 859-864.
20. Jiang, Z.X.; Yu, Y.B. The design and synthesis of highly branched and spherically symmetric fluorinated oils and amphiles. Tetrahedron 2007, 63, 3982-3988.
21. Janjic, J.M.; Ahrens, E.T. Compositions and Methods for Producing Cellular Labels for Nuclear Magnetic Resonance Techniques. U.S. Patent 8,227,610, 12 March 2009.
22. Soman, N.R.; Lanza, G.M.; Heuser, J.M.; Schlesinger, P.H.; Wickline, S.A. Synthesis and characterization of stable fluorocarbon nanostructures as drug delivery vehicles for cytolytic peptides. Nano Lett. 2008, 8, 1131-1136.
23. 19F magnetic resonance imaging for stem/progenitor cell tracking with multiple unique perfluorocarbon nanobeacons. FASEB J. 2007, 21, 1647-1654.
24. Strickley, R.G. Solubilizing excipients in oral and injectable formulations. Pharm. Res. 2004, 21, 201-230.
25. Rowe, R.C.; Sheskey, P.J.; Cook, W.G.; Fenton, M.E.; American Pharmacists Association. Handbook of Pharmaceutical Excipients, 7th ed.; APhA/Pharmaceutical Press: London, UK, 2012, p. 1033.
26. Reimund, J.M.; Rahmi, G.; Escalin, G.; Pinna, G.; Finck, G.; Muller, C.D.; Duclos, B.; Baumann, R. Efficacy and safety of an olive oil-based intravenous fat emulsion in adult patients on home parenteral nutrition. Aliment. Pharmacol. Ther. 2005, 21, 445-454.
27. Heurtault, B.; Saulnier, P.; Pech, B.; Proust, J.E.; Benoit, J.P. Physico-chemical stability of colloidal lipid particles. Biomaterials 2003, 24, 4283-4300.
28. Putyatina, T.K.; Aprosin, U.D.; Afonin, N.I. The elimination peculiarities of perfluorocarbon emulsions stabilized with egg yolk phospholipid. Artif. Cells Blood Substit. Immobil. Biotechnol. 1994, 22, 1281-1285.
29. Maa, Y.F.; Hsu, C.C. Performance of sonication and microfluidization for liquid-liquid emulsification. Pharm. Dev. Technol. 1999, 4, 233-240.
30. Hatton, T.A.; Alexandridis, P. Poly(ethylene oxide)-poly(propylene oxide )-poly (ethylene oxide) block copolymer surfactants in aqueous solutions and at interfaces: Thermodynamics, structure, dynamics, and modeling. Colloids Surfaces A: Physicochem. Eng. Asp. 1995, 96, 1-46.
31. Uskokovic, V.; Odsinada, R.; Djordjevic, S.; Habelitz, S. Dynamic light scattering and zeta potential of colloidal mixtures of amelogenin and hydroxyapatite in calcium and phosphate rich ionic milieus. Arch. Oral Biol. 2011, 56, 521-532.
32. Hu, L.; Chen, J.; Yang, X.; Caruthers, S.D.; Lanza, G.M.; Wickline, S.A. Rapid quantification of oxygen tension in blood flow with a fluorine nanoparticle reporter and a novel blood flow-enhanced-saturation-recovery sequence. Magn. Reson. Med. 2013, 70, 176-183.
33. Zhong, J.; Mills, P.H.; Hitchens, T.K.; Ahrens, E.T. Accelerated fluorine-19 MRI cell tracking using compressed sensing. Magn. Reson. Med. 2013, 69, 1683-1690.
34. Kadayakkara, D.K.; Janjic, J.M.; Pusateri, L.K.; Young, W.B.; Ahrens, E.T. In vivo observation of intracellular oximetry in perfluorocarbon-labeled glioma cells and chemotherapeutic response in the CNS using fluorine-19 MRI. Magn. Reson. Med. 2010, 64, 1252-1259.
35. 19F MRI for quantitative in vivo cell tracking. Trends Biotechnol. 2010, 28, 363-370.